CD19 and neoplasm: Adoptive transfer of CD19+ B cells from 67NR tumor–bearing mice reduces RANKL production by 4T1-specific CD3+ T cells, restores trabecular bone mass in vivo, and inhibits 4T1 metastatic dissemination in vivo